Mechanisms involved in cardiac sensitization by volatile anesthetics: General applicability to halogenated hydrocarbons?

Critical Reviews in Toxicology

Volumn 38, Issue 9, 2008, Pages 773-803

  Himmel, Herbert M ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Action potential; Automaticity; Catecholamines; Conduction; Halocarbons; Halothane; Ion channels; Triangulation

Indexed keywords

ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CATECHOLAMINE; HALOGENATED HYDROCARBON; INHALATION ANESTHETIC AGENT; MUSCARINIC RECEPTOR; POTASSIUM CHANNEL HERG; SODIUM CHANNEL;

ACTION POTENTIAL; ARRHYTHMOGENESIS; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; ELECTRIC CONDUCTIVITY; HUMAN; NONHUMAN; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ACTION POTENTIALS; ANESTHETICS, INHALATION; ANIMALS; ARRHYTHMIAS, CARDIAC; CATECHOLAMINES; HEART; HUMANS; HYDROCARBONS, HALOGENATED; ION CHANNELS;

EID: 54349128111     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440802237664     Document Type: Review

References (277)

1. Abraham, M.H., Lieb, W.R., and Franks, N.P. (1991). Role of hydrogen bonding in general anesthesia. J. Pharm. Sci. 80:719-724.
2. Adir, J., Blake, D.A., and Mergner, G.M. (1975). Pharmacokinetics of fluorocarbon 11 and 12 in dogs and humans. J. Clin. Pharmacol. 15:760-770.
3. Aguado-Matorras, A. (1974). Comparative study of myocardial sensitization to norepinephrine under halothane and enflurane anesthesia. Acta Anaesthesiol. Belgica 25:198-205.
4. Alexander, D.J., Mortimer, E., Dines, G.D., Libretto, S.E., and Mallett, D.N. (1995). One-year study in dogs of the toxicity of HFA-134a by inhalation. Inhal. Toxicol. 7:1153-1162.
5. Amin, Y.M., Thompson, E.B., and Chiou, W.L. (1979). Fluorocarbon aerosol propellants XII: Correlation of blood level of trichloromonofluoromethane to cardiovascular and respiratory responses in anesthetized dogs. J. Pharm. Sci. 68:160-163.
6. Angerer, J., Schroeder, B., and Heinrich, R. (1985). Exposure to fluorotrichloromethane (R-11). Int. Arch. Occup. Environ. Health 56:67-72.
7. Annau, Z. (1981). The neurobehavioral toxicity of trichloroethylene. Neurobehav. Toxicol. Teratol. 3:417-424.
8. Anthony, B.L., Dennison, R.L., and Aronstam, R.S. (1989). Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci. Lett. 99:191-196.
9. Antti-Poika, M., Heikkilä, J., and Saarinen, L. (1990). Cardiac arrhythmias during occupational exposure to fluorinated hydrocarbons. Br. J. Ind. Med. 47:138-140.
10. Anyukhovsky, E.P., Guo, S.D., Danilo, P., and Rosen, M.R. (1997). Responses to norepinephrine of normal and "ischemic" canine Purkinje fibers are consistent with activation of different α1-receptor subtypes. J. Cardiovasc. Electrophysiol. 8:658-666.
11. Arias, C., Gonzalez, T., Moreno, I., Caballero, R., Delpon, E., Tamargo, J., and Valenzuela, C. (2003). Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on hERG channels. Cardiovasc. Res. 57:660-669.
12. Asai, T., Kusudo, K., Ikeda, H., Takenoshita, M., and Murase, K. (2002). Effect of halothane on neuronal excitation in the superficial dorsal horn of rat spinal cord slices: Evidence for a presynaptic action. Eur. J. Neurosci. 15:1278-1290.
13. Astier, A., and Paraire, F. (1997). Fatal intoxication with 1,1-dichloro-1-fluoroethane. N. Engl. J. Med. 337:940.
14. Atlee, J.L., and Malkinson, C.E. (1982). Potentiation by thiopental of halothane-epinephrine-induced arrhythmias in dogs. Anesthesiology 57:285-288.
15. Azar, A., Trochimowicz, H.J., Terrill, J.B., and Mullin, L.S. (1973). Blood levels of fluorocarbon related to cardiac sensitization. Am. Ind. Hyg. Assoc. J. 34:102-109.
16. + channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Am. J. Physiol. 282:H2024-H2030.
17. Bass, M. (1970). Sudden sniffing death. J. Am. Med. Assoc. 212:2075-2079.
18. Beck, P.S., Clark, D.G., and Tinston, D.J. (1973). The pharmacologic actions of bromochlorodifluoromethane (BCF). Toxicol. Appl. Pharmacol. 24:20-29.
19. Beckstead, M.J., Phelan, R., and Mihic, S.J. (2001). Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. J. Biol. Chem. 276:24959-24964.
20. A receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 57:1199-1205.
21. Boachie-Ansah, G., Kane, K.A., and Parratt, J.R. (1989). Cardiac electrophysiological effects of isoprenaline, phenylephrine, and noradrenaline on normal and mildly "ischaemic" sheep Purkinje fibers. J. Cardiovasc. Pharmacol. 13:291-298.
22. iα. Mol. Pharmacol. 45:380-389.
23. Böhm, M., Schmidt, U., Schwinger, R.H.G., Böhm, S., and Erdmann, E. (1993). Effects of halothane on β-adrenoceptors and M-cholinoceptors in human myocardium: Radioligand binding and functional studies. J. Cardiovasc. Pharmacol. 21:296-304.
24. Bosnjak, Z.J., Supan, F.D., and Rusch, N.J. (1991). The effects of halothane, enflurane, and isoflurane on calcium current in isolated canine ventricular cells. Anesthesiology 74:340-345.
25. Breindahl, T. (2000). Therapeutic drug monitoring of flecainide in serum using high-performance liquid chromatography and electronspray mass spectrometry. J. Chromatogr. B 746:249-254.
26. Brock, W.J., Rusch, G.M., and Trochimowicz, H.J. (2003). Cardiac sensitization: Methodology and interpretation in risk assessment. Regul. Toxicol. Pharmacol. 38:78-90.
27. Brock, W.J., Trochimowicz, H.J., Millischer, R.J., Farr, C., Kawano, T., and Rusch, G.M. (1995). Acute and subchronic toxicity of 1,1-dichloro-1- fluoroethane (HCFC-141b). Food Chem. Toxicol. 33:483-490.
28. Brode, E., Müller-Peltzer, H., and Hollmann, M. (1988). Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man. Methods Find. Exp. Clin. Pharmacol. 10:717-27.
29. 3H- norepinephrine in guinea-pig atria. Anesthesiology 36:263-267.
30. Buss, J., Neuss, H., Bilgin, Y., and Schlepper, M. (1985). Malignant ventricular tachyarrhythmias in association with propafenone treatment. Eur. Heart J. 6:424-428.
31. Calkins, D.S., Degioanni, J.J., Tan, M.N., Davis, J.R., and Pierson, D.L. (1993). Human performance and physiological function during a 24-hr exposure to 1% bromotrifluoromethane (halon 1301). Fundam. Appl. Toxicol. 20:240-247.
32. Campagna, J.A., Miller, K.W., and Forman, S.A. (2003). Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med. 348:2110-2124.
33. Carceles, M.D., Laorden, M.L., Hernandez, J., Miralles, F.S., and Campos, M. (1990). Halothane, isoflurane and enflurane potentiate the effect of noradrenaline on ventricular automaticity in the rat heart: evidence of the involvement of both α- or β-adrenoceptors. J. Pharm. Pharmacol. 42:186-190.
34. Carter, V.L., Back, K.C., and Farrer, D.N. (1970). The effect of bromotrifluoromethane on operant behaviour in monkeys. Toxicol. Appl. Pharmacol. 17:648-655.
35. Chen, X., Cordes, J.S., Bradley, J.A., Sun, Z.Q., and Zhou, J. (2006). Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs. J. Pharmacol. Toxicol. Methods 54:261-272.
36. Chen, X.D., Yamakage, M., Yamada, Y., Tohse, N., and Mamiki, A. (2002). Inhibitory effects of volatile anesthetics on currents produced on heterologous expression of KvLQT1 and minK in Xenopus oocytes. Vasc. Pharmacol. 39:33-38.
37. Chen, L.S., Zhou, S.M., Fishbein, M.C., and Chen, P.S. (2007). New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J. Cardiovasc. Electrophysiol. 18:123-127.
38. Chiou, J.S., Krishna, P.R., Kamaya, H., Ueda, I. (1992). Alcohols dehydrate lipid membranes: an infrared study on hydrogen bonding. Biochim. Biophys. Acta 1110:225-233.
39. Chou, Y.H., Wei, J., and Lin, C. (1991). Halothane inhibits residual fast sodium channels in human atrial muscle. Anesthesiology 75:716-717.
40. Claborn, L.D., and Szabuniewicz, M. (1973). Prevention of chloroform and thiobarbiturate cardiac sensitization to catecholamines in dogs. Am. J. Vet. Res. 34:801-804.
41. Clark, D.G., and Tinston, D.J. (1973). Correlation of the cardiac sensitization potential of halogenated hydrocarbons with their physicochemical properties. Br. J. Pharmacol. 49:355-357.
42. Clark, D.G., and Tinston, D.J. (1982). Acute inhalation toxicity of some halogenated and non-halogenated hydrocarbons. Hum. Toxicol. 1:239-247.
43. Colatsky, T.J., Follmer, C.H., and Starmer, C.F. (1990). Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82:2235-2242.
44. Coote, J.H. (2007). Landmarks in understanding the central nervous control of the cardiovascular system. Exp. Physiol. 92:3-18.
45. + channels are differentially modified by general anesthetics. Am. J. Physiol. 275:C1009-C1021.
46. Cranefield, P.F. (1977). Action potentials, afterpotentials, and arrhythmias. Circ. Res. 41:415-423.
47. Cruz, S.L., Balster, R.L., and Woodward, J.J. (2000). Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 131:1303-1308.
48. Daniels, S., and Smith, E.B. (1993). Effects of general anaesthetics on ligand-gated ion channels. Br. J. Anaesth. 71:59-64.
49. + current in rat ventricular myocytes. Br. J. Pharmacol. 131:223-230.
50. Dekant, W. (1996). Toxicology of chlorofluorocarbon replacements. Environ. Health Perspect. 104(suppl. 1):75-83.
51. Delgado, C., Tamargo, J., and Tejerina, T. (1985). Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres. Br. J. Pharmacol. 86:765-775.
52. + current in guinea-pig ventricular myocytes: Voltage-independent and time-dependent block of the slowly activating component. Circ. Res. 76:223-235.
53. Dildy-Mayfield, J.E., Eger, E.I., and Harris, R.A. (1996). Anesthetics produce subunit-selective actions on glutamate receptors. J. Pharmacol. Exp. Ther. 276:1058-1065.
54. Dollery, C.T. (1973). Absorption and fate of isoproterenol and fluorocarbons inhaled from pressurized aerosols. Ann. Allergy 31:25-30.
55. Downie, D.L., Vicente-Agullo, F., Campos-Caro, A., Bushell, T.J., Lieb, W.R., and Franks, N.P. (2002). Determinants of the anesthetic sensitivity of neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 277:10367-10373.
56. Duan, D., Fermini, B., and Nattel, S. (1993). Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J. Pharmacol. Exp. Ther. 264:1113-1123.
57. ECETOC. (1994). 1,1-Dichloro-1-fluoroethane (HCFC-141b). Joint Assess. Commod. Chem. 29:1-46.
58. ECETOC. (1994). Pentafluoroethane (HFC-125). Joint Assess. Commod. Chem. 24:1-35.
59. ECETOC. (1995). Difluoromethane (HFC-32). Joint Assess. Commod. Chem. 32:1-23.
60. ECETOC. (2004). 1-Chloro-1,2,2,2-tetrafluoroethane (HCFC-124). Joint Assess. Commod. Chem. 46:1-52.
61. ECETOC. (2005). 1,1-Dichloro-2,2,2-trifluoroethane (HCFC-123). Joint Assess. Commod. Chem. 47:1-101.
62. ECETOC. (2006). 1,1,1,2-Tetrafluoroethane (HFC-134a). Joint Assess. Commod. Chem. 50:1-79.
63. Edling, C., Ohlson, C.G., Ljungkvist, G., Oliv, A., and Söderholm, B. (1990). Cardiac arrhythmia in refrigerator repairmen exposed to fluorocarbons. Br. J. Ind. Med. 47:207-212.
64. Egeland, G.M., Bloom, T.F., Schnorr, T.M., Hornung, R.W., Suruda, A.J., and Wille, K.K. (1992). Fluorocarbon 113 exposure and cardiac dysrhythmias among aerospace workers. Am. J. Ind. Med. 22:851-857.
65. Elliott, J.R., Elliott, A.A., Harper, A.A., and Winpenny, J.P. (1992). Effects of general anaesthetics on neuronal sodium and potassium channels. Gen. Pharmacol. 23:1005-1011.
66. Ellis, M.K., Trebilcock, R., Naylor, J.L., Tseung, K., Collins, M.A., Hext, P.M., and Green, T. (1996). The inhalation toxicology, genetic toxicology, and metabolism of difluoromethane in the rat. Fundam. Appl. Toxicol. 31:243-251.
67. El-Maghrabi, E.A., Eckenhoff, R.G., and Shuman, H. (1992). Saturable binding of halothane to rat brain synaptosomes. Proc. Natl. Acad. Sci. USA 89:4329-4332.
68. Emmen, H.H., Hoogendijk, E.M.G, Klöpping-Ketelaars, W.A.A., Muijser, H., Duistermaat, E., Ravensberg, J.C., Alexander, D.J., Borkhataria, D., Rusch, G.M., and Schmit, B. (2000). Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a° (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3,3-heptafluoropropane) following whole-body exposure. Regul. Toxicol. Pharmacol. 32:22-35.
69. Engel, G.L. (1971). Sudden and rapid death during psychological stress. Folklore or folk wisdom? Ann. Int. Med. 74:771-782.
70. Eskinder, H., Rusch, N.J., Supan, F.D., Kampine, J.P., and Bosnjak, Z.J. (1991). The effect of volatile anesthetics on L- and T-type calcium channel currents in canine cardiac Purkinje cells. Anesthesiology 74:919-926.
71. Eskinder, H., Supan, F.D., Turner, L.A., Kampine, J.P., and Bosnjak, Z.J. (1993). The effects of halothane and isoflurane on slowly inactivating sodium current in canine cardiac Purkinje cells. Anesth. Analg. 77:32-37.
72. Esler, M.D., Alvarenga, M., Lambert, G., Kaye, D., Hastings, J., Jennings, G., Morris, M., Schwarz, R., and Richards, J. (2004). Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Ann. NY Acad. Sci. 1018:505-514.
73. Esler, M., Alvarenga, M., Pier, C., Richards, J., El-Osta, A., Barton, D., Haikerwal, D., Kaye, D., Schlaich, M., Guo, L., Jennings, G., Socratous, F., and Lambert, G. (2006). The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J. Psychopharmacol. 20(suppl.):60-66.
74. Estes, N.A., Garan, H., and Ruskin, J.N. (1984). Electrophysiologic properties of flecainide acetate. Am. J. Cardiol. 53:26B-29B.
75. Fei, L., Gill, J.S., McKenna, W.J., and Camm, J. (1993). Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig. Br. J. Pharmacol. 109:178-182.
76. Flanagan, R.J., Ruprah, M., Meredith, T.J., and Ramsey, J.D. (1990).An introduction to the clinical toxicology of volatile substances. Drug Safety 5:359-383.
77. K, by flecainide and E-4031 in cat ventricular myocytes. Circulation 82:289-293.
78. Follmer, C.H., Cullinan, C.A., and Colatsky, T.J. (1992). Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: Evidence for open channel block and unblock. Cardiovasc. Res. 26:1121-1130.
79. Franks, N.P., and Lieb, W.R. (1984). Do general anaesthetics act by competitive binding to specific receptors? Nature 310:599-601.
80. + current. Nature 333:662-664.
81. Franks, N.P., and Lieb, W.R. (1991). Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science 254:427-430.
82. Franks NP, and Lieb, W.R. (1993). Selective actions of volatile general anaesthetics at molecular and cellular levels. Br. J. Anaesth. 71:65-76.
83. Franks, N.P., and Lieb, W.R. (1994). Molecular and cellular mechanisms of general anaesthesia. Nature 367:607-614.
84. max to conduction velocity. Anesth. Analg. 72:5-10.
85. Freeman, L.C., and Muir, W.W. (1991b). α-Adrenoceptor stimulation in the presence of halothane: effects on impulse propagation in cardiac Purkinje fibers. Anesth. Analg. 72:11-17.
86. Fujikawa, H., Sato, Y., Arakawa, H., Mitsuhashi, T., Minezaki, K., Kuroki, S., Sekiguchi, H., Nakayama, T., Ikeda, U., and Shimada, K. (1998). Induction of Torsades de Pointes by dobutamine infusion in a patient with idiopathic long QT syndrome. Int. Med. 37:149-152.
87. ATP channels by isoflurane. Br. J. Pharmacol. 149:573-580.
88. Funck-Brentano, C., Kroemer, H.K., Lee, J.T., and Roden, D.M. (1990). Propafenone. N. Engl. J. Med. 322:518-525.
89. Gallagher, J.D., Weindling, S.N., Anderson, G., and Fillinger, M.P. (1998). Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome. Anesthesiology 89:1569-1573.
90. Gomez, R.S., and Guatimosim, C. (2003). Mechanism of action of volatile anesthetics: Involvement of intracellular calcium signaling. Curr. Drug Targets CNS Neurol. Disord. 2:123-129.
91. Grant, A.O., and Tranquillo, J. (2007). Action potential and QT prolongation not sufficient to cause Torsades de Pointes: Role of action potential triangulation. J. Cardiovasc. Electrophysiol. 18:204-205.
92. Groppi, A., Polettini, A., Lunetta, P., Achille, G., and Montagna, M. (1994). A fatal case of trichlorofluoromethane (Freon 11) poisoning. Tissue distribution study by gas chromatography-mass spectrometry. J. Forens. Sci. 39:871-876.
93. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 65:443-452.
94. Gunnare, S., Ernstgard, L., Sjögren, B., and Johanson, G. (2006). Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure. Toxicol. Lett. 167:54-65.
95. Guo, D., Zhao, X.J., Wu, Y., Liu, T.X., Kowey, P.R., and Yan, G.X. (2007). L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J. Cardiovasc. Electrophysiol. 18:196-203.
96. Hamlin, R.L., Cruze, C.A., Mittelstadt, S.W., Kijtawornrat, A., Keene, B.W., Roche, B.M., Nakayama, T., Nakayama, H., Hamlin, D.M., and Arnold, T. (2004). Sensitivity and specificity of isolated perfused guinea-pig heart to test for drug-induced lengthening of QTc. J. Pharmacol. Toxicol. Methods 49:15-23.
97. Hancox, J.C., and Mitcheson, J.S. (1997). Inhibition of L-type calcium current by propafenone in single myocytes isolated from the rabbit atrioventricular node. Br. J. Pharmacol. 121:7-14.
98. Hantson, P., Vandenplas, O., Dive, A., and Mahieu, P. (1990). Trichloroethylene and cardiac toxicity: report of two consecutive cases. Acta Clin. Belg. 45:34-37.
99. Hardman, J.G., Goodman-Gilman, A., and Limbird, L.E. (eds.). (1995). Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York.
100. Harron, D.W., and Brogden, R.N. (1987). Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 34:617-647.
101. Hashimoto, K., and Hashimoto, K. (1972). The mechanism of sensitization of the ventricle to epinephrine by halothane. Am. Heart J. 83:652-658.
102. Hayashi, Y., Sumikawa, K., Yamatodani, A., Tashiro, C., Wada, H., and Yoshiya, I. (1989). Myocardial sensitization by thiopental to arrhythmogenic action of epinephrine in dogs. Anesthesiology 71:929-935.
103. Hayashi, Y., Sumikawa, K., Yamatodani, A., Kamibayashi, T., Kuro, M., and Yoshiya, I. (1991). Myocardial epinephrine sensitization with subanesthetic concentrations of halothane in dogs. Anesthesiology 74:134-137.
104. Hede, A.R., Berglund, B.C., and Post, C. (1987). Trichloroethylene and halothane inhibit uptake and metabolism of 5-hydroxytryptamine in rat lung slices. Pharmacol. Toxicol. 61:191-194.
105. Hede, A.R., and Post, C. (1982). Trichloroethylene and halothane inhibit uptake of 5-hydroxytryptamine in the isolated perfused rat lung. Biochem. Pharmacol. 31:353-358.
106. Hellestrand, K.J., Bexton, R.S., Nathan, A.W., Spurrell, R.A., and Camm, A.J. (1982). Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Br. Heart J. 48:140-148.
107. Hescheler, J., Halbach, M., Egert, U., Lu, Z.J., Bohlen, H., Fleischmann, B.K., and Reppel, M. (2004). Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J. Electrocardiol. 37(suppl.):110-116.
108. + channel involved in neuroprotection and general anesthesia. EMBO J. 23:2684-2695.
109. Hii, J.T.Y., Wyse, G., Gillis, A.M., Cohen, J.M., and Mitchell, L.B. (1991). Propafenone-induced Torsades de Pointes: Cross-reactivity with quinidine. Pacing Clin. Electrophysiol. 14:1568-1570.
110. Hirota, K., Ito, Y., Kuze, S., and Momose, Y. (1992). Effects of halothane on electrophysiologic properties and cyclic adenosine 3′,5′-monophosphate content in isolated guinea-pig hearts. Anesth. Analg. 74:564-569.
111. Hirota, K., Ito, Y., Masuda, A., and Momose, Y. (1989). Effects of halothane on membrane ionic currents in guinea-pig atrial and ventricular myocytes. Acta Anaesthesiol. Scand. 33:239-244.
112. Hondeghem, L.M. (2007). Relative contributions of TRIaD and QT to proarrhythmia. J. Cardiovasc. Electrophysiol. 18:655-657.
113. Hondeghem, L.M., and Hoffmann, P. (2003). Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: Importance of triangulation, reverse use-dependence, and instability. J. Cardiovasc. Pharmacol. 41:14-24.
114. Hondeghem, L.M., Lu, H.R., van Rossem, K., and De Clerck, F. (2003). Detection of proarrhythmia in the female rabbit heart: Blinded validation. J. Cardiovasc. Electrophysiol. 14:287-294.
115. Honjo, H., Watanabe, T., Kamiya, K., Kodama, I., and Toyama, J. (1989). Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts. Br. J. Pharmacol. 97:731-738.
116. Hüneke, R., Fassl, J., Rossaint, R., and Lückhof, A. (2004). Effects of volatile anesthetics on cardiac ion channels. Acta Anaesthesiol. Scand. 48:547-561.
117. ICH. (2005). ICH guideline S7B (CPMP/ICH/423/02). The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. http://www.emea.europa.eu/pdfs/human/ ich/042302en.pdf.
118. Ikemoto, Y., Yatani, A., Imoto, Y., and Arimura, H. (1986). Reduction in the myocardial sodium current by halothane and thiamylal. Jpn. J. Physiol. 36:107-121.
119. Jiao, Z., de Jesus, V.R., Iravanian, S., Campbell, D.P., Xu, J., Vitali, J.A., Banach, K., Fahrenbach, J., and Dudley, S.C. (2006).Apossible mechanism of halocarbon-induced cardiac sensitization arrhythmias. J. Mol. Cell. Cardiol. 41:698-705.
120. Johansson, J.S. (1998). Fatal intoxication with 1,1-dichloro=1- fluoroethane. N. Engl. J. Med. 338:201-202.
121. Johnston, R.R., Eger, E.I., and Wilson, C. (1976). A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man. Anesth. Analg. 55:709-712.
122. 2+ currents of rat reticular thalamic neurones and their modulation by ebflurane. J. Physiol. (Lond.) 566:125-142.
123. A receptor β3 subunit. FASEB J. 17:250-252.
124. Kamatchi, G.L., Durieux, M.E., and Lynch, C. (2001). Differential sensitivity of expressed L-type calcium channels and muscarinic M1 receptors to volatile anesthetics in Xenopus oocytes. J. Pharmacol. Exp. Ther. 297:981-990.
125. 2+ channels through enhancement of current inactivation. Br. J. Anaesth. 82:402-411.
126. Kamiya, K., Kannan, R., Matin-Asgari, A., and Singh, B.N. (1989). Electrophysiologic effects of flecainide relative to serum and tissue concentrations in rabbits after chronic drug administration. J. Cardiovasc. Pharmacol. 14:25-30.
127. Kang, J., Reynolds, W.P., Chen, X.L., Ji, J., Wang, H., and Rampe, D.E. (2006). Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. Anesthesiology 104:1015-1022.
128. Karagueuzian, H.S., Fujimoto, T., Katoh, T., Peter, T., McCullen, A., and Mandel, W.J. (1982) Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine. Circulation 66:1190-1198.
129. Katchman, A.N., Koerner, J., Tosaka, T., Woosley, R.L., and Ebert, S.N. (2006). Comparative evaluation of hERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J. Pharmacol. Exp. Ther. 316:1098-106.
130. Katritsis, D., Rowland, E., O'Nunain, S., Shakespeare, C.F., Poloniecki, J., and Camm, A.J. (1995). Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Eur. Heart J. 16:1930-1935.
131. Katz, R.L., and Katz, G.J. (1966). Surgical infiltration of pressor drugs and their interaction with volatile anaesthetics. Br. J. Anaesth. 38:712-718.
132. Kaufman, J.D., Morgan, M.S., Marks, M.L., Greene, H.L., and Rosenstock, L. (1992). A study of the cardiac effects of bromochlorodifluoromethane (halon 1211) exposure during exercise. Am. J. Ind. Med. 21:223-233.
133. Kaufman, J.D., Silverstein, M.A., and Moure-Eraso, R. (1994). Atrial fibrillation and sudden death related to occupational solvent exposure. Am. J. Ind. Med. 25:731-735.
134. Kawachi, I., Colditz, G.A., Ascherio, A., Rimm, E.B., Giovannucci, E., Stampfer, M.J., and Willett, W.C. (1994a). Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89:1992-1997.
135. Kawachi, I., Sparrow, D., Vokonas, P.S., and Weiss, S.T. (1994b). Symptoms of anxiety and risk of coronary heart disease. The normative aging study. Circulation 90:2225-2229.
136. Kawano, T., Trochimowicz, H.J., Malinverno, G., and Rusch, G.M. (1995). Toxicological evaluation of 1,1,1,2,2-pentafluoroethane (HFC-125). Fundam. Appl. Toxicol. 28:223-231.
137. Keller, K., Meyer-Estorf, G., Beck, O.A., and Hochrein, H. (1978). Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone. Eur. J. Clin. Pharmacol. 13:17-20.
138. King, G.S., Smialek, J.E., and Troutman, W.G. (1985). Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. J. Am. Med. Assoc. 253:1604-1606.
139. Kitamura, A., Marszalec, W., Yeh, J.Z., and Narahashi, T. (2003). Effects of halothane and propofol on excitatory and inhibitory synaptic transmission in rat cortical neurons. J. Pharmacol. Exp. Ther. 304:162-171.
140. Kohlhardt, M., and Seifert, C. (1980). Inhibition of Vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 315:55-62.
141. Konietzko, H., and Elster, I. (1973). Toxic effects on heart of trichloroethylene. Arch. Toxikol. 31:93-98.
142. Koreeda, A., Yonemitsu, K., Mimasaka, S., Ohtsu, Y., and Tsunenari, S. (2007). An accidental death due to Freon 22 (monochlorodifluoromethane) inhalation in a fishing vessel. Forens. Sci. Int. 168:208-211.
143. Krasowski, M.D., and Harrison, N.L. (1999). General anaesthetic actions on ligand-gated ion channels. Cell. Mol. Life Sci. 55:1278-1303.
144. Kubota, T., and Miyata, A. (2005). Acute inhalational exposure to chlorodifluoromethane (Freon-22): A report of 43 cases. Clin. Toxicol. 43:305-308.
145. Kuenszberg, E., Loeckinger, A., Kleinsasser, A., Lindner, K.H., Puehringer, F., and Hoermann, C. (2000). Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur. J. Anaesthesiol. 17:662-664.
146. 1- adrenoceptor-induced conduction depression in canine cardiac Purkinje fibers. Anesthesiology 92:1713-1721.
147. Lam, C.W., Weir, F.W., Williams-Cavender, K., Tan, M.N., Galen, T.J., and Pierson, D.L. (1993). Toxicokinetics of inhaled bromotrifluoromethane (halon 1301) in human subjects. Fundam. Appl. Toxicol. 20:231-239.
148. Lerman, Y., Winkler, E., Tirosh, M.S., Danon, Y., and Almog, S. (1991). Fatal accidental inhalation of bromochlorodifluoromethane (halon 1211). Hum. Exp. Toxicol. 10:125-128.
149. Lesage, F. (2003). Pharmacology of neuronal background potassium channels. Neuropharmacology 44:1-7.
150. Lessard, Y., Callec, J.J., and Paulet, G. (1980). Action du difluorodichloromethane (FC-12) sur l'activite electrique cardiaque de mammifere au niveau cellulaire. C. R. Seances Soc. Biol. Fil. 174:52-57.
151. Lessard, Y., Desbrousses, S., and Paulet, G. (1977). Arythmie cardiaque chez le chien sous l'action de l'adrenaline et du difluorodichloromethane (FC-12). C. R. Seances Soc. Biol. Fil. 171:1270-1282.
152. Lessard, Y., and Paulet, G. (1985). Mechanism of liposoluble drugs and general anesthetics membrane action: Action of difluorodichloromethane (FC-12) on different types of cardiac fibers isolated from sheep hearts. Cardiovasc. Res. 19:465-473.
153. Lessard, Y., and Paulet, G. (1986). A proposed mechanism for cardiac sensitization: Electrophysiological study of effects of difluorodichloromethane and adrenaline on different types of cardiac preparations isolated from sheep hearts. Cardiovasc. Res. 20:807-815.
154. 2 adrenergic sedative dexmedetomidine, and cannabinoid agonists. J. Pharmacol. Exp. Ther. 317:615-626.
155. 2+ channels, and GABAA receptors. Br. J. Anaesth. 90:199-211.
156. Lown, B., and Wolf, M. (1971). Approaches to sudden death from coronary heart disease. Circulation 44:130-142.
157. Lui, H.K., Lee, G., Dietrich, P., Low, R.I., and Mason, D.T. (1982). Flecainide-induced QT prolongation and ventricular tachycardia. Am. Heart J. 103:567-569.
158. Lysko, G.S., Robinson, J.L., Casto, R., and Ferrone, R.A. (1994). The stereospecific effects of isoflurane isomers in-vivo. Eur. J. Pharmacol. 263:25-29.
159. Malfatto, G., Zaza, A., Forster, M., Sodowick, B., Danilo, P., and Rosen, M.R. (1988). Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. J. Pharmacol. Exp. Ther. 246:419-426.
160. Maze, M., and Smith, C.M. (1983). Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog. Anesthesiology 59:322-326.
161. McDowell, T.S., Pancrazio, J.J., Barrett, P.Q., and Lynch, C. (1999). Volatile anesthetic sensitivity of T-type calcium currents in various cell types. Anesth. Analg. 88:168-173.
162. Mergenthaler, J., Haverkamp, W., Hüttenhofer, A., Skryabin, B.V., Musshoff, U., Borggrefe, M., Speckmann, E.J., Breithardt, G., and Madeja, M. (2001). Blocking effects of the antiarrhythmic drug propafenone on the hERG potassium channel. Naunyn-Schmiedeberg's Arch. Pharmacol. 363:472-480.
163. Metz, S., and Maze, M. (1985). Halothane concentration does not alter the threshold for epinephrine-induced arrhythmias in dogs. Anesthesiology 62:470-474.
164. Meyer, T., Boven, K.H., Günther, E., and Fejtl, M. (2004). Microelectrode arrays in cardiac safety pharmacology. A novel tool to study QT interval prolongation. Drug Safety 27:763-772.
165. Mihic, S.J., Ye, Q., Wick, M.J., Koltchine, V.V., Krasowski, M.D., Finn, S.E., Mascia, M.P., Valenzuela, C.F., Hanson, K.K., Greenblatt, E.P., Harris, R.A., and Harrison, N.L. (1997). Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 389:385-389.
166. Milberg, P., Hilker, E., Ramtin, S., Cakir, Y., Stypmann, J., Engelen, M.A., Mönnig, G., Osada, N., Breithardt, G., Haverkamp, W., and Eckardt, L. (2007). Proarrhythmia as a class effect of quinolones: Increased dispersion of repolarization and triangulation of action potential predict Torsades de Pointes. J. Cardiovasc. Electrophysiol. 18:647-654.
167. Miletich, D.J., Khan, A., Albrecht, R.F., and Jozefiak, A. (1983). Use of heart cell cultures as a tool for the evaluation of halothane arrhythmia. Toxicol. Appl. Pharmacol. 70:181-187.
168. Mohamed, U., Napolitano, C., and Priori, S.G. (2007). Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J. Cardiovasc. Electrophysiol. 18:791-797.
169. Moore, M.A., Weiskopf, R.B., Eger, E.I., and Wilson, C. (1993). Arrhythmogenic doses of epinephrine are similar during desflurane or isoflurane anesthesia in humans. Anesthesiology 79:943-947.
170. Mullin, L.S., Reinhardt, C.F., and Hemingway, R.E. (1979). Cardiac arrhythmias and blood levels associated with inhalation of Halon 1301. Am. Ind. Hyg. Assoc. J. 40:653-658.
171. Naito, H., and Gillis, C.N. (1968). Anesthetics and response of atria to sympathetic nerve stimulation. Anesthesiology 29:259-266.
172. Nakao, S., Hirata, H., and Kagawa, Y. (1989). Effects of volatile anesthetics on cardiac calcium channels. Acta Anaesthesiol. Scand. 33:326-330.
173. Nathan, A.W., Hellestrand, K.J., Bexton, R.S., Spurrell, R.A., and Camm, A.J. (1985). The proarrhythmic effects of flecainide. Drugs 29(Suppl. 4):45-53.
174. Nattel, S., and Carlsson, L. (2006). Innovative approaches to anti-arrhythmic drug therapy. Nat. Rev. Drug Discov. 5:1034-1049.
175. Navarro, R., Weiskopf, R.B., Moore, M.A., Lockhart, S., Eger, E.I., Koblin, D., Lu, G., and Wilson, C. (1994). Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine. Anesthesiology 80:545-549.
176. Ngai, S.H., Diaz, P.M., and Ozer, S. (1969). The uptake and release of norepinephrine: Effects of cyclopropane and halothane. Anesthesiology 31:45-52.
177. Niggli, E., Rüdisüli, A., Maurer, P., and Weingart, R. (1989). Effects of general anesthetics on current flow across membranes in guinea-pig myocytes. Am. J. Physiol. 256:C273-C281.
178. Nikoronov, I.M., Blanck, T.J.J., and Recio-Pinto, E. (1998). The effects of halothane on single human neuronal L-type calcium channels. Anesth. Analg. 86:885-895.
179. Okuda, M., Kunitsugu, I., Kobayakawa, S., and Hobara, T. (2001). Inhibitory effect of 1,1,1-trichloroethane on calcium channels of neurons. J. Toxicol. Sci. 26:169-176.
180. Otsuka, M. (1958). Die Wirkung von Adrenalin auf Purkinje-Fasern von Säugetierherzen. Pfluegers Arch. 266:512-517.
181. 2+ channel current in guinea-pig myocytes. J. Physiol. (Lond.) 494:91-103.
182. + channels. Nat/Neurosci. 2:422-426.
183. Patel, M.K., Mistry, D., John, J.E. III, and Mounsey, J.P. (2000). Sodium channel isoform-specific effects of halothane: Protein kinase C coexpression and slow inactivation gating. Br. J. Pharmacol. 130: 1785-1792.
184. Paul, A.A., Witchel, H.J., and Hancox, J.C. (2002). Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br. J. Pharmacol. 136:717-729.
185. Paulet, G., and Lessard, Y. (1975). The effect of difluorodichloromethane (FC-12) on isolated rat and rabbit heart. C. R. Seances Soc. Biol. Fil. 169:1048-1053.
186. Pillekamp, F., Reppel, M., Brockmeier, K., and Hescheler, J. (2006). Impulse propagation in late-stage embryonic and neonatal murine ventricular slices. J. Electrocardiol. 39:425.e1-425.e4.
187. Priori, S.G., and Corr, P.B. (1990). Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am. J. Physiol. 258:H1796-H1805.
188. Puttick, R.M., and Terrar, D.A. (1992). Effects of propofol and enflurane on action potentials, membrane currents and contration of guinea-pig isolated ventricular myocytes. Br. J. Pharmacol. 107:559-565.
189. Ramos, K.S., Chacon, E., and Acosta, D. (1996). Toxic responses of the heart and vascular system. In: Klaassen, C.D. (ed.), Casarett & Doull's Toxicology. The Basic Science of Poisons. McGraw-Hill, New York, pp. 487-527.
190. Ratnakumari, L., and Hemmings, H.C. (1998). Inhibition of presynaptic sodium channels by halothane. Anesthesiology 88:1043-1054.
191. Ratnakumari, L., Vysotskaya, T.N., Duch, D.S., and Hemmings, H.C. (2000). Differential effects of anesthetic and non-anesthetic cyclobutanes on neuronal voltage-gated sodium channels. Anesthesiology 92:529-541.
192. Redfern, W.S., Carlsson, L., Davis, A.S., Lynch, W.G., MacKenzie, I., Palethorpe, S., Siegl, P.K., Strang, I., Sullivan, A.T., Wallis, R., Camm, A.J., and Hammond, T.G. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58:32-45.
193. Rehnqvist, N., Ericsson, C.G., Eriksson, S., Olsson, G., and Svensson, G. (1984). Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction. Acta Med. Scand. 216:525-530.
194. Reinhardt, C.F., Azar, A., Maxfield, M.E., Smith, P.E., and Mullin, L.S. (1971). Cardiac arrhythmias and aerosol "sniffing." Arch. Environ. Health 22:265-279.
195. Reppel, M., Igelmund, P., Egert, U., Juchelka, F., Hescheler, J., and Drobschinskaya, I. (2007). Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. 19:213-224.
196. Reynolds, A.K. (1984). On the mechanism of myocardial sensitization to catecholamines by hydrocarbon anesthetics. Can. J. Physiol. Pharmacol. 62:183-198.
197. Ritchie, G.D., Kimmel, E.C., Bowen, L.E., Reboulet, J.E., and Rossi, J. (2001). Acute neurobehavioral effects in rats from exposure to HFC 134a or CFC 12. NeuroToxicology 22:233-248.
198. + current in subendocardial and subepicardial myocytes from the rat left ventricle. Anesth. Analg. 99:1615-1622.
199. Roden, D.M., Balser, J.R., George, A.L., and Anderson, M.E. (2002). Cardiac ion channels. Annu. Rev. Physiol. 64:431-475.
200. Rodstein, M., Wolloch, L., and Gubner, R.S. (1971). Mortality study of the significance of extrasystoles in an insured population. Circulation 44:617-625.
201. Rosengarten, M., and Brooks, R. (1987). Torsade de pointes ventricular tachycardia in a hypothyroid patient treated with propafenone. Can. J. Cardiol. 3:234-239.
202. Rudolph, U., and Antkowiak, B. (2004). Molecular and neuronal substrates for general anaesthetics. Nature Rev. Neurosci. 5:709-720.
203. Rudolph, U., and Möhler. H. (2004). Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu. Rev. Pharmacol. Toxicol. 44:475-498.
204. Sakata, M., Kazama, H., Miki, A., Yoshida, A., Haga, M., and Morita, M. (1981). Acute toxicity of fluorocarbon-22: Toxic symptoms, lethal concentration, and its fate in rabbit and mouse. Toxicol. Appl. Pharmacol. 59:64-70.
205. Samuels, M.A. (2007). The brain-heart connection. Circulation 116:77-84.
206. Sarubbi, B., Ducceschi, V., Briglia, N., Esposito, R., Mayer, M.S., Scialdone, A., Santangelo, L., and Iacono, A. (1996). Sotalol, propafenone, and flecainide: Compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy. Cardiologia 41:645-651.
207. Sarubbi, B., Ducceschi, V., Briglia, N., Mayer, M.S., Santangelo, L., and Iacono, A. (1998). Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. Int. J. Cardiol. 66:157-64.
208. Satoh, H., and Hashimoto, K. (1984). Effects of propafenone on the membrane currents of rabbit sino-atrial node cells. Eur. J. Pharmacol. 99:185-191.
209. Schlepper, M. (1987). Propafenone, a review of its profile. Eur. Heart J. 8(suppl.A):27-32.
210. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J. Pharmacol. Exp. Ther. 269:66-74.
211. Schmeling, W.T., Warltier, D.C., McDonald, D.J., Madsen, K.E., Atlee, J.L., and Kampine, J.P. (1991). Prolongation of the Q Tinterval by enflurane, isoflurane, and halothane in humans. Anesth. Analg. 72:137-144.
212. Scholz, E.P., Alter, M., Zitron, E., Kiesecker, C., Kathöfer, S., Thomas, D., Kreye, V.A.W., Kreuzer, J., Becker, R., Katus, H.A., Greten, J., and Karle, C.A. (2006). In-vitro modulation of hERG channels by organochlorine solvent trichloromethane as potential explanation for proarrhythmic effects of chloroform. Toxicol. Lett. 165:156-166.
213. 2+ channel function by volatile organic solvents. J. Pharmacol. Exp. Ther. 315:1109-1118.
214. Shepherd, R.T. (1989). Mechanism of sudden death associated with volatile substance abuse. Hum. Toxicol. 8:287-292.
215. + current in guinea-pig ventricular cells. J. Pharmacol. Sci. 95:363-373.
216. + channels in rat cerebellar granule neurons by halothane, isoflurane, and sevoflurane. Anesth. Analg. 96:1340-1344.
217. Shiraishi, M., and Harris, R.A. (2004). Effects of alcohols and anesthetics on recombinant voltage-gated Na+ channels. J. Pharmacol. Exp. Ther. 309:987-994.
218. + channel is a molecular substrate for neuronal effects of inhalation anesthetics. J. Neurosci. 20:6347-6354.
219. Skrzypiec-Spring, M., Grotthus, B., Szelag, A., and Schulz, R. (2007). Isolated heart perfusion according to Langendorff - Still viable in the new millenium. J. Pharmacol. Toxicol. Methods 55:113-126.
220. Smith, R.D., and Pettway, C.E. (1975). Absence of sensitization to epinephrine-induced cardiac arrhythmia and fibrillation in dogs and cats anesthetized with CI-744. Am. J. Vet. Res. 36:695-698.
221. Snyder, R., Bakshi, K.S., and Wagner, B.M. (1997). Abstracts of the workshop on toxicity of alternatives to chlorofluorocarbons. Inhal. Toxicol. 9:775-810.
222. Sonner, J.M., Antognini, J.F., Dutton, R.C., Flood, P., Gray, A.T., Harris, R.A., Homanics, G.E., Kendig, J., Orser, B., Raines, D.E., Trudell, J., Vissel, B., and Eger, E.I. (2003). Inhaled anesthetics and immobility: Mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth. Analg. 97:718-740.
223. + current by halothane and isoflurane. Anesth. Analg. 90:824-833.
224. Stadnicka, A., Kwok, W.M., Hartmann, H.A., and Bosnjak, Z.J. (1999). Effects of halothane and isoflurane on fast and slow inactivation of human heart hH1a sodium channels. Anesthesiology 90:1671-1683.
225. Steidl, E.M., Neveu, E., Bertrand, D., and Buisson, B. (2006). The adult rat hippocampal slice revisited with multi-electrode arrays. Brain Res. 1096:70-84.
226. Steinbeck, G. (1983). Tachykarde Rhythmusstörungen. In: Lüderitz, B. (ed.), Herzrhythmusstörungen. Springer, Berlin-Heidelberg-New York, pp. 617-641.
227. Sumikawa, K., Ishizaka, N., and Suzaki, M. (1983). Arrhythmogenic plasma levels of epinephrine during halothane, enflurane, and pentobarbital anesthesia in the dog. Anesthesiology 58:322-325.
228. Suzuki, A., Bosnjak, Z.J., and Kwok, W.M. (2003). The effects of isoflurane on the cardiac slowly activating delayed-rectifier potassium channel in guinea-pig ventricular myocytes. Anesth. Analg. 96:1308-1315.
229. Takahara, A., Sugiyama, A., and Hashimoto, K. (2005a). Reduction of repolarization reserve by halothane anaesthesia sensitizes the guineapig heart for drug-induced QT interval prolongation. Br. J. Pharmacol. 146:561-567.
230. Takahara, A., Sugiyama, A., Satoh, Y., Wang, K., Honsho, S., and Hashimoto, K. (2005b). Halothane sensitizes the canine heart to pharmacological IKr blockade. Eur. J. Pharmacol. 507:169-177.
231. Takahashi, H., Puttick, R.M., and Terrar, D.A. (1994). The effects of propofol and enflurane on single calcium channel currents of guinea-pig isolated ventricular myocytes. Br. J. Pharmacol. 111:1147-1153.
232. Takenoshita, M., and Steinbach, J.H. (1991). Halothane blocks low-voltage-activated calcium current in rat sensory neurons. J. Neurosci. 11:1404-1412.
233. Tas, P.W.L., Kress, H.G., and Koschel, K. (1987). Volatile anesthetics and n-alkanols inhibit the uptake of noradrenaline into pheochromocytoma cells. Anaesthesist 36:340-344.
234. Ter Keurs, H.E.D.J., and Boyden, P.A. (2007). Calcium and arrhythmogenesis. Physiol. Rev. 87:457-506.
235. Terrar, D.A., and Victory, J.G. (1988). Influence of halothane on electrical coupling in cell pairs isolated from guinea-pig ventricle. Br. J. Pharmacol. 94:509-514.
236. Terrenoire, C., Lauritzen, I., Lesage, F., Romey, G., and Lazdunski, M. (2001).ATREK-1-like potassium channel in atrial cells inhibited by β-adrenergic stimulation and activated by volatile anesthetics. Circ. Res. 89:336-342.
237. Terrenoire, C., Piriou, V., Bonvallet, R., Chouabe, C., Espinosa, L., Rougier, O., and Tourneur, Y. (2000). Opposite effects of halothane on guinea-pig ventricular action potential duration. Eur. J. Pharmacol. 390:95-101.
238. Thevenin, J., Da Costa, A., Roche, F., Romeyer, C., Messier, M., and Isaaz, K. (2003). Flecainide induced ventricular tachycardia (torsades de pointes). Pacing Clin. Electrophysiol. 26:1907-1908.
239. Thompson, E.B., and Galysh, F.T. (1973). Quantitative assessment of anesthetic-induced cardiac sensitization to epinephrine. Anesth. Analg. 52:800-806.
240. Thompson, K.A., Iansmith, D.H.S., Siddoway, L.A., Woosley, R.L., and Roden, D.M. (1988). Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers. J. Pharmacol. Exp. Ther. 244:950-955.
241. Tranquilli, W.J., Thurmon, J.C., Benson, G.J., and Davis, L.E. (1986). Alteration in the arrhythmogenic dose of epinephrine (ADE) following xylazine administration to halothane-anesthetized dogs. J. Vet. Pharmacol. Ther. 9:198-203.
242. Trochimowicz, H.J., Azar, A., Terrill, J.B., and Mullin, L.S. (1974). Blood levels of fluorocarbon related to cardiac sensitization: Part II. Am. Ind. Hyg. Assoc. J. 35:632-639.
243. Turner, L.A., Marijic, J., Kampine, J.P., and Bosnjak, Z.J. (1990). A comparison of the effects of halothane and tetrodotoxin on the regional repolarization characteristics of canine Purkinje fibers. Anesthesiology 73:1158-1168.
244. Turner, L.A., Polic, S., Hoffmann, R.G., Kampine, J.P., and Bosnjak, Z.J. (1993a). Actions of halothane and isoflurane on Purkinje fibers in the infarcted canine heart: Conduction, regional refractoriness, and reentry. Anesth. Analg. 76:718-725.
245. Turner, L.A., Polic, S., Hoffmann, R.G., Kampine, J.P., and Bosnjak, Z.J. (1993b). Actions of volatile anesthetics on ischemic and nonischemic Purkinje fibers in the infarcted canine heart: Regional action potential characteristics. Anesth. Analg. 76:726-733.
246. A receptors: Relevance to theories of narcosis. Anesth. Analg. 88:877-883.
247. Valentin, J.P., Hoffmann, P., De Clerck, F., Hammond, T.G., and Hondeghem, L. (2004). Reviewof the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. J. Pharmacol. Toxicol. Methods 49:171-181.
248. Vanhoutte, F., Vereecke, J., Carmeliet, E., and Verbeke, N. (1991). Effects of the enantiomers of flecainide on action potential characteristics in the guinea-pig papillary muscle. Arch. Int. Pharmacol. Ther. 310:102-114.
249. Venugopalan, C.S., Holmes, E., and O'Malley, N.A. (1989). Comparison of arrhythmogenic doses of epinephrine in heartworm-infected and noninfected dogs. Am. J. Vet. Res. 50:1872-1876.
250. Vinegar, A., and Jepson, G.W. (1996). Cardiac sensitization thresholds of halon replacement chemicals predicted in humans by physiologically-based pharmakokinetic modeling. Risk Anal. 16:571-579.
251. Vinegar, A., Jepson, G.W., Cisneros, M., Rubinstein, R., and Brock, W.J. (2000). Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling. Inhal. Toxicol. 12:751-763.
252. Vodanovic, S., Turner, L.A., Hoffmann, R.G., Kampine, J.P., and Bosnjak, Z.J. (1997). Actions of phenylephrine, isoproterenol, and epinephrine with halothane on endocardial conduction and activation in canine left ventricular papillary muscles. Anesthesiology 87:117-126.
253. Vos, M.A., van Opstal, J.M., Leunissen, J.D.M., and Verduyn, S.C. (2001). Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsades de Pointes arrhythmias. Pharmacol. Ther. 92:109-122.
254. + conductance. J. Neurosci. 22:1256-1265.
255. Waters, E.M., Gerstner, H.B., and Huff, J.E. (1977). Trichloroethylene - An overview. J. Toxicol. Environ. Health 2:671-707.
256. Weigl, L.G., and Schreibmayer, W. (2001). G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics. Mol. Pharmacol. 60:282-289.
257. Weigt, H.U., Kwok, W.M., Rehmert, G.C., and Bosnjak, Z.J. (1998a). Modulation of the cardiac sodium current by inhalational anesthetics in the absence and presence of β-stimulation. Anesthesiology 88:114-124.
258. 1-adrenergic stimulation by inhalation anesthetics. Evidence for distinct modulatory pathways. Anesthesiology 88:125-133.
259. Weigt, H.U., Kwok, W.M., Rehmert, G.C., Turner, L.A., and Bosnjak, Z.J. (1997a). Voltage-dependent effects of volatile anesthetics on cardiac sodium current. Anesth. Analg. 84:285-293.
260. 1-stimulation and volatile anesthetics. Anesthesiology 87:1507-1516.
261. + current. Anesthesiology 87:1494-1506.
262. Weissenburger, J., Nesterenko, V.V., and Antzelevitch, C. (2000). Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in-vivo: Torsades de Pointes develops with halothane but not pentobarbital anesthesia. J. Cardiovasc. Electrophysiol. 11:290-304.
263. White, J.F., and Carlson, G.P. (1981). Epinephrine-induced cardiac arrhythmias in rabbits exposed to trichloroethylene: Role of trichloroethylene metabolites. Toxicol. Appl. Pharmacol. 60:458-465.
264. Wickers, F., Haissaguere, M., and Palussiere, J. (1988). QT prolongation and induction of torsade de pointe by flecainide. Apropos of a case. Arch. Mal. Coeur Vaiss. 81:1283-1285.
265. Wilkinson, D.J.C., Thompson, J.M., Lambert, G.W., Jennings, G.L., Schwarz, R.G., Jefferys, D., Turner, A.G., and Esler, M.D. (1998). Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch. Gen. Psychiatry 55:511-520.
266. Winslow, E., and Campbell, J.K. (1991). Comparative frequency-dependent effects of three class Ic agents, ORG 7797, flecainide, and propafenone, on ventricular action potential duration. J. Cardiovasc. Pharmacol. 18:911-917.
267. Witchel, H.J., Dempsey, C.E., Sessions, R.B., Perry, M., Milnes, J.T., Hancox, J.C., and Mitcheson, J.S. (2004). The low-potency, voltage-dependent hERG blocker propafenone: Molecular determinants and drug trapping. Mol. Pharmacol. 66:1201-1212.
268. 2+ transport in ventricular myocytes from streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 261:251-262.
269. Woollen, B.H., Guest, E.A., Howe, W., Marsh, J.R., Wilson, H.K., Auton, T.R., and Blain, P.G. (1990) Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane (FC113). Int. Arch. Occup. Environ. Health 62:73-78.
270. Woollen, B.H., Marsh, J.R., Mahler, J.D., Auton, T.R., Makepeace, D., Cocker, J., and Blain, P.G. (1992) Human inhalation pharmacokinetics of chlorodifluoromethane (HCFC22). Int. Arch. Occup. Environ. Health 64:383-387.
271. Xiang, G.X., Pan, L.B., Huang, L., Yu, Z.Y., Song, X.D., Cheng, J., Xing, W., and Zhou, Y.X. (2007). Microelectrode array-based system for neuropharmacological applications with cortical neurons cultured in-vitro. Biosensors Bioelectron. 22:2478-2484.
272. Yamada, M., Hatakeyama, N., Malykhina, A.P., Yamazaki, M., Momose, Y., and Akbarali, H.I. (2006). The effects of sevoflurane and propofol on QT interval and heterologously expressed human ether-a-go-go-related gene currents in Xenopus oocytes. Anesth. Analg. 102:98-103.
273. Yamamoto, K., Tamura, T., Imai, R., and Yamamoto, M. (2001). Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation - Influences of anesthesia and validation with quinidine and astemizole. Toxicol. Sci. 60:165-176.
274. Yost, C.S. (2000) .Tandem pore domain K channels: An important site of volatile anesthetic action? Curr. Drug Targets 1:207-217.
275. + channels. Curr. Drug Targets 4:347-351.
276. Zolk, O., and Eschenhagen, T. (2004). Kardiotoxizität. In: Marquardt, H., and Schäfer, S. (eds.), Lehrbuch der Toxikologie. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp. 557-578.
277. Zordoky, B.N.M., and El-Kadi, A.O.S. (2007). H9c2 cell line is a valuable in-vitro model to study the drug metabolizing enzymes in the heart. J. Pharmacol. Toxicol. Methods 56:317-322.